AI For Pharma Growth

In this episode, we delve into the transformative role of artificial intelligence (AI) in healthcare with Dr. Steven Charlap, founder and CEO of SOAP Health. Driven by a deeply personal mission to prevent misdiagnosis and save lives, Dr. Charlap shares his journey from a career as a general surgeon to pioneering AI-powered solutions that are changing the medical landscape. We explore: How SOAP Hea...

In this episode, we dive into the transformative power of artificial intelligence (AI) in the pharmaceutical industry with Noah Healey , a computational mathematician and creator of coordinated discovery markets . Noah shares his journey from studying nuclear engineering to pioneering innovative solutions at the intersection of AI, healthcare, and business models . We explore: How AI is addressing...

In this episode, we explore the principles of trustworthy AI with Pamela Gupta, Chief AI Governance and Trust Officer and founder of Trusted AI. Pamela shares her journey of building a company dedicated to responsible and ethical AI. She introduces the eight essential pillars of trustworthy AI, focusing on critical aspects such as transparency, fairness, bias mitigation, privacy, and security. The...

In this episode of AI for Pharma Growth , Dr. Andree Bates chats with Sam Libby, President and Managing Director at TCB Capital Advisors. With decades of experience in healthcare investment banking, Sam shares his insights into the transformative role of artificial intelligence (AI) in diagnostics and patient care, as well as the exciting investment opportunities in emerging technologies. From the...

 In this episode, we explore how artificial intelligence (AI) is bridging healthcare gaps with Richard Kedziora, Co-Founder/COO Estenda Solutions, a leader in digital health innovation. Richard shares how his company leverages AI to tackle disparities in healthcare access, improve personalised medicine, and streamline back-office workflows. We discuss the transformative impact of wearables, remot...

In this episode, we explore the fascinating intersection of artificial intelligence (AI) and academic publishing with Gráinne McNamara, a Research Integrity and Publication Ethics Manager. Gráinne shares her insights on how AI is revolutionising the publishing process, helping to detect plagiarism, image manipulation, and ensuring reproducibility in scientific research. We discuss the ethical chal...

In this episode, we explore how artificial intelligence (AI) is transforming the pharmaceutical industry with Ilyssa Levins, founder and CEO of SecureChek.ai. Ilyssa shares how her company is automating and streamlining the creation and compliance of pharma marketing materials, cutting approval times from months to days while ensuring error-free submissions. We discuss the outdated manual processe...

In this episode, we explore how artificial intelligence is revolutionising health equity. Dr Rav Seeruthun, co-founder and CEO of HealthEquity. AI, shares his journey from practising medicine to leading a pioneering AI-driven healthcare initiative. We discuss the biggest misconceptions about health equity, how AI can uncover hidden disparities in healthcare data, and the importance of actionable i...

In this episode, we explore how artificial intelligence (AI) reflects and often amplifies gender bias from the real world. Sandra Struebing, head of the Global Women Employee Network and a data and AI specialist, joins us to discuss the roots of gender bias in AI and how to address it effectively. Sandra shares her insights on how data drives AI models and how biases in training data can perpetuat...

In this episode of AI for Pharma Growth , Dr. Andree Bates explores the critical issue of cybersecurity in healthcare with Terry Ziemniak, a cybersecurity leader with over 20 years of experience. Terry shares insights into why healthcare is one of the most targeted industries for cyberattacks and what organisations can do to protect sensitive data while maintaining accessibility. Together, they di...

In this episode of AI for Pharma Growth , Dr. Andree Bates hosts Dr. Louis Rosenberg, founder and CEO of Unanimous AI, to discuss the revolutionary impact of swarm intelligence on group decision-making and forecasting in the pharmaceutical industry and beyond. Dr. Rosenberg explains how Unanimous AI's platforms—Swarm and ThinkScape—enhance the collective wisdom of groups, allowing organisations to...

In this episode, we explore the intersection of artificial intelligence (AI) and healthcare supply chains with Philip Ashton, founder and CEO of 7bridges. As healthcare systems globalise, the pharmaceutical supply chain becomes increasingly complex and vulnerable to disruptions. Ashton reveals how AI and real-world data are revolutionising supply chain management, allowing for greater visibility,...

In this episode, Dr Andree Bates sits down with Dr Jayne Morgan, Vice President of Medical Affairs and On-Air Medical Expert. They discuss the transformative role of artificial intelligence (AI) in patient care, telehealth, and the future of diagnostics. Dr Morgan provides an insider’s perspective on the challenges and ethical concerns facing AI-driven healthcare, from physician burnout to data bi...

In this episode, we dive into the future of cancer treatment with Dr. Sola Adeleke, founder and CEO of Curenetics. Dr. Adeleke shares how his company is using artificial intelligence (AI) to predict cancer treatment outcomes and improve the personalisation of cancer therapies, particularly in immunotherapy. We explore the key challenges of current treatment methods, the role of genomics and imagin...

In this episode, Dr. Andree Bates speaks with Dr. Jordan Lane, Chief Scientific Officer of Ignota Labs, about how explainable AI is transforming the pharmaceutical industry. They explore how Ignota Labs leverages AI to rescue drug projects that previously failed due to safety concerns. Dr. Lane highlights the groundbreaking technology behind the Safe Path platform, which integrates chem-informatic...

In this episode of "AI for Pharma Growth" Dr Andree Bates sits down with Ken Pomella, CEO of RevStar, to delve into the intricate balance between innovation and ethical responsibility in the development of AI technologies. They explore the ethical challenges that AI poses, particularly in the pharmaceutical and healthcare sectors, and discuss ways to ensure that AI advances without causing harm. F...

In this episode of AI for Pharma Growth, Dr. Andree Bates sits down with Cav. Franco Lofranco, CEO of APM Global, to explore how artificial intelligence is revolutionising the healthcare industry, making it more affordable and accessible. They discuss the challenges of the current healthcare system in the United States, including high costs and inequitable access, and highlight how new technology,...

In this episode, host Dr. Andree Bates sits down with Raj Bhattacharya, who previously headed the go-to-market function for pharma and life sciences at One Network. Raj shares his extensive background in the pharmaceutical industry, having worked in production, formulations R&D, and supply chain roles for companies like AstraZeneca and Allergan.   Raj highlights the key challenges facing pharma su...

This episode of AI for Pharma Growth features an interview with Noah Kjos, the Co-Founder and COO of DeepTrust, a company that offers an AI tool to authenticate whether an audio recording was generated by an AI voice or a human voice.   Andree and Noah discuss the growing threat of deep fake audio scams and the importance of being able to verify the authenticity of voice communications, particular...

This episode of AI for Pharma Growth features an interview with Torrey Smith, the Co-Founder and CEO of Endiatx, a company developing a revolutionary robotic pill that can provide a non-invasive way to observe inside the human body.   Torrey explains the journey of Endiatx, progressing from a startup in a Silicon Valley garage to clinical trials and engagement with leading healthcare institutions,...

This episode features an interview with Marco Baldocchi, the founder and CEO of the Marco Baldocchi Group, who specialises in leveraging AI in neuromarketing. Marco discusses his background in marketing and economics, and how a personal experience with buying a car led him to explore the unconscious decision-making processes of consumers.   Marco explains how neuromarketing techniques, such as EEG...

In this episode, Dr. Andree Bates speaks to Mariana Matus, the co-founder and CEO of Biobot, a company that is transforming wastewater infrastructure into public health observatories.   Mariana explains the concept of wastewater epidemiology, where wastewater samples from communities are collected and analysed for various disease indicators, including COVID-19, influenza, and substances of concern...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Xander Kerman Gregory, the Head of Growth at Ubie Health, to discuss the company's innovative work in early disease prediction through the power of artificial intelligence.   Ubie Health focussed on user-centric design to dynamically guide patients through a series of carefully selected questions to quickly arrive at the most l...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by IdentifAI founders Justin Marciano and Paul Vann to explore the deep fake challenge and the innovative solutions they are developing. The pair share their unique backgrounds and motivations for founding the company, emphasising the critical need to address the growing threat of synthetic media and its far-reaching consequences...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Vinoth Nageshwaran, a leading data engineer currently working at Business Insider. Vinoth discusses the challenges of large language models (LLMs) like ChatGPT, which often hallucinate or generate inaccurate information due to their lack of true understanding and ability to verify facts.   Vinoth explains how the use of retriev...